DIAZEPAM ORAL SOLUTION (CONCENTRATE)

DIAZEPAM ORAL SOLUTION (CONCENTRATE) was reported 90058 times

DIAZEPAM ORAL SOLUTION (CONCENTRATE) is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RHESUS INCOMPATIBILITY 68 0.5620
1 TOTAL LUNG CAPACITY INCREASED 108 0.3971
2 CONGENITAL NYSTAGMUS 79 0.3726
3 VISCERAL CONGESTION 139 0.2720
4 MYOGLOBIN URINE PRESENT 64 0.2602
5 VITAL CAPACITY DECREASED 104 0.2321
6 SUBSTANCE USE DISORDER 687 0.2154
7 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 110 0.2103
8 REVERSIBLE AIRWAYS OBSTRUCTION 104 0.2047
9 STIFF PERSON SYNDROME 62 0.1787
10 BRADYPNOEA 383 0.1418
11 EXPOSURE VIA FATHER 185 0.1418
12 SPUTUM CULTURE POSITIVE 111 0.1367
13 MULTIPLE DRUG OVERDOSE ACCIDENTAL 61 0.1335
14 MULTIPLE DRUG THERAPY 96 0.1273
15 VICTIM OF CHEMICAL SUBMISSION 82 0.1222
16 VICTIM OF CRIME 148 0.1196
17 DRUG USE DISORDER 957 0.1137
18 MIOSIS 826 0.1028
19 POISONING DELIBERATE 934 0.0984
20 ACCIDENTAL DEATH 178 0.0957
21 COMA SCALE ABNORMAL 277 0.0955
22 AGORAPHOBIA 128 0.0935
23 SEDATION COMPLICATION 237 0.0928
24 POISONING 1084 0.0862
25 COGWHEEL RIGIDITY 90 0.0857
26 BRONCHIAL SECRETION RETENTION 108 0.0848
27 MULTIPLE DRUG OVERDOSE 410 0.0825
28 SUBSTANCE ABUSE 667 0.0819
29 RESPIRATORY DEPRESSION 936 0.0763
30 DRUG ABUSE 6198 0.0744
31 HYPOMANIA 265 0.0720
32 PSYCHOGENIC SEIZURE 67 0.0717
33 DROWNING 68 0.0672
34 GASTRIC PH DECREASED 68 0.0663
35 ALCOHOL POISONING 177 0.0660
36 ALCOHOL INTERACTION 121 0.0622
37 NEUROLEPTIC MALIGNANT SYNDROME 738 0.0622
38 DRUG WITHDRAWAL CONVULSIONS 109 0.0612
39 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 62 0.0584
40 JAUNDICE CHOLESTATIC 200 0.0566
41 ACCIDENTAL POISONING 77 0.0561
42 MULTIPLE DRUG OVERDOSE INTENTIONAL 180 0.0559
43 EXPOSURE VIA INGESTION 140 0.0554
44 HYPERPARATHYROIDISM SECONDARY 138 0.0550
45 TOXICITY TO VARIOUS AGENTS 9223 0.0546
46 SCHIZOPHRENIA 647 0.0532
47 RESPIRATORY ARREST 1400 0.0507
48 DEREALISATION 107 0.0497
49 NYSTAGMUS 260 0.0489
50 PSYCHOTIC SYMPTOM 101 0.0489
51 H1N1 INFLUENZA 68 0.0484
52 REBOUND ACID HYPERSECRETION 146 0.0482
53 NEPHROGENIC ANAEMIA 223 0.0481
54 ASPHYXIA 391 0.0478
55 COMA 2271 0.0476
56 SMALL FOR DATES BABY 232 0.0467
57 COMPLETED SUICIDE 3881 0.0465
58 LOGORRHOEA 156 0.0442
59 DRUG TOXICITY 594 0.0436
60 ANTIPSYCHOTIC DRUG LEVEL INCREASED 118 0.0419
61 SEROTONIN SYNDROME 800 0.0416
62 SOPOR 546 0.0412
63 ARTERIOSCLEROSIS CORONARY ARTERY 272 0.0410
64 ALCOHOL ABUSE 109 0.0407
65 PERSONALITY DISORDER 106 0.0404
66 ANXIETY DISORDER 135 0.0404
67 TEARFULNESS 173 0.0402
68 RESPIRATORY ACIDOSIS 158 0.0402
69 HALLUCINATIONS, MIXED 168 0.0399
70 ELECTROENCEPHALOGRAM ABNORMAL 126 0.0399
71 STATUS EPILEPTICUS 446 0.0395
72 POTENTIATING DRUG INTERACTION 132 0.0393
73 DISINHIBITION 63 0.0391
74 DEPRESSED LEVEL OF CONSCIOUSNESS 1527 0.0386
75 MYDRIASIS 495 0.0385
76 HYPOVENTILATION 124 0.0380
77 STUPOR 122 0.0379
78 MULTIPLE-DRUG RESISTANCE 117 0.0377
79 SCHIZOAFFECTIVE DISORDER 66 0.0370
80 BRADYPHRENIA 241 0.0369
81 INTENTIONAL OVERDOSE 2362 0.0368
82 SALIVARY HYPERSECRETION 366 0.0365
83 STRABISMUS 107 0.0364
84 AUTONOMIC NERVOUS SYSTEM IMBALANCE 105 0.0359
85 BLOOD PH DECREASED 61 0.0357
86 ALTERED STATE OF CONSCIOUSNESS 767 0.0354
87 SUICIDAL BEHAVIOUR 147 0.0353
88 SUICIDE ATTEMPT 2110 0.0348
89 SNORING 131 0.0346
90 PERSECUTORY DELUSION 86 0.0345
91 SEDATION 896 0.0342
92 PNEUMONIA ASPIRATION 835 0.0334
93 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 86 0.0328
94 CARDIO-RESPIRATORY ARREST 1367 0.0327
95 CREATININE RENAL CLEARANCE DECREASED 129 0.0322
96 CATATONIA 168 0.0320
97 INTENTIONAL SELF-INJURY 644 0.0319
98 ACUTE PSYCHOSIS 78 0.0315
99 RHINITIS ALLERGIC 140 0.0314
100 NEUROLOGICAL DECOMPENSATION 72 0.0311
101 BEHAVIOUR DISORDER 167 0.0308
102 PSYCHOTIC DISORDER 909 0.0307
103 PHYSICAL ASSAULT 64 0.0306
104 CLONUS 83 0.0303
105 HYPOTHERMIA 304 0.0300
106 MUSCLE RIGIDITY 354 0.0296
107 RESPIRATORY RATE DECREASED 92 0.0293
108 PSYCHOMOTOR RETARDATION 81 0.0288
109 SELF-INJURIOUS IDEATION 119 0.0283
110 SELF INJURIOUS BEHAVIOUR 86 0.0282
111 BRAIN OEDEMA 356 0.0282
112 ASPIRATION 306 0.0279
113 PSYCHOMOTOR SKILLS IMPAIRED 73 0.0278
114 DISSOCIATION 213 0.0278
115 PARADOXICAL DRUG REACTION 102 0.0277
116 DROOLING 191 0.0276
117 LONG QT SYNDROME 66 0.0275
118 CLUMSINESS 75 0.0275
119 AGGRESSION 1374 0.0274
120 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 169 0.0273
121 HYPERREFLEXIA 95 0.0272
122 FEELING OF DESPAIR 127 0.0272
123 PULMONARY CONGESTION 359 0.0272
124 AGITATION 1973 0.0268
125 TOXIC ENCEPHALOPATHY 135 0.0266
126 EOSINOPHIL COUNT DECREASED 63 0.0264
127 BRADYKINESIA 155 0.0262
128 DIABETES INSIPIDUS 63 0.0261
129 SARCOIDOSIS 124 0.0261
130 SINUS TACHYCARDIA 367 0.0258
131 DELUSION 399 0.0257
132 AKATHISIA 347 0.0254
133 SELF-MEDICATION 104 0.0253
134 DRUG DIVERSION 156 0.0252
135 PARKINSONISM 244 0.0250
136 LEFT VENTRICULAR HYPERTROPHY 107 0.0250
137 POSTURE ABNORMAL 81 0.0249
138 HYPERTHERMIA 189 0.0247
139 DRUG ABUSER 152 0.0247
140 DRUG SCREEN POSITIVE 194 0.0245
141 DRUG INTERACTION 3889 0.0245
142 AORTIC ARTERIOSCLEROSIS 63 0.0245
143 SUDDEN DEATH 256 0.0242
144 RESTLESSNESS 883 0.0241
145 HOSTILITY 61 0.0240
146 DYSARTHRIA 903 0.0240
147 ATAXIA 282 0.0237
148 NASAL POLYPS 114 0.0231
149 DYSAESTHESIA 70 0.0228
150 ACCIDENTAL OVERDOSE 834 0.0228
151 PARANOIA 388 0.0225
152 ALCOHOL USE 83 0.0225
153 WITHDRAWAL SYNDROME 942 0.0224
154 TROPONIN INCREASED 170 0.0223
155 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 114 0.0222
156 HYPERACUSIS 82 0.0220
157 CARDIAC ARREST 1814 0.0219
158 AMYLASE INCREASED 81 0.0219
159 GENERALISED TONIC-CLONIC SEIZURE 360 0.0217
160 DELIRIUM 753 0.0217
161 SUICIDAL IDEATION 1940 0.0212
162 SUSPECTED SUICIDE 99 0.0211
163 CARDIAC MURMUR 182 0.0210
164 HALLUCINATION, AUDITORY 334 0.0210
165 FEELING OF BODY TEMPERATURE CHANGE 122 0.0208
166 DYSTONIA 402 0.0207
167 SOCIAL AVOIDANT BEHAVIOUR 119 0.0205
168 HYPOTONIA 205 0.0205
169 DRUG LEVEL ABOVE THERAPEUTIC 94 0.0205
170 THROMBOCYTOSIS 75 0.0204
171 ELECTROCARDIOGRAM QT PROLONGED 729 0.0202
172 PARTIAL SEIZURES 106 0.0202
173 DEPRESSIVE SYMPTOM 71 0.0201
174 THERAPEUTIC AGENT TOXICITY 67 0.0201
175 UNRESPONSIVE TO STIMULI 516 0.0200
176 MUSCLE CONTRACTIONS INVOLUNTARY 70 0.0199
177 POST-TRAUMATIC STRESS DISORDER 133 0.0198
178 INTENTIONAL DRUG MISUSE 413 0.0197
179 BRAIN DEATH 61 0.0197
180 END STAGE RENAL DISEASE 359 0.0197
181 CARDIOMEGALY 242 0.0197
182 INCONTINENCE 207 0.0196
183 BRONCHOPNEUMONIA 67 0.0195
184 HYPERTONIA 112 0.0195
185 CHRONIC KIDNEY DISEASE 1482 0.0195
186 OBSTRUCTIVE AIRWAYS DISORDER 214 0.0192
187 TOXIC EPIDERMAL NECROLYSIS 292 0.0192
188 BRONCHIECTASIS 129 0.0191
189 HEPATIC NECROSIS 72 0.0191
190 HEPATIC STEATOSIS 353 0.0189
191 PSYCHOMOTOR HYPERACTIVITY 312 0.0188
192 SENSORY LOSS 151 0.0187
193 NEUTROPHIL COUNT INCREASED 192 0.0187
194 RENAL FUNCTION TEST ABNORMAL 87 0.0187
195 CARDIOPULMONARY FAILURE 73 0.0187
196 CYANOSIS 294 0.0187
197 PANIC ATTACK 676 0.0185
198 MYOCLONUS 221 0.0185
199 INTERVERTEBRAL DISC DISORDER 79 0.0185
200 HOMICIDAL IDEATION 75 0.0185
201 HYPOPNOEA 64 0.0184
202 PETIT MAL EPILEPSY 94 0.0184
203 TENSION 112 0.0184
204 DRUG LEVEL INCREASED 304 0.0183
205 PANIC DISORDER 71 0.0183
206 ACIDOSIS 140 0.0183
207 CEREBRAL ATROPHY 73 0.0183
208 COMMUNICATION DISORDER 70 0.0183
209 MANIA 298 0.0181
210 SOMNOLENCE 3636 0.0180
211 SINUS BRADYCARDIA 174 0.0180
212 COORDINATION ABNORMAL 251 0.0180
213 HAEMODYNAMIC INSTABILITY 137 0.0180
214 MONOPLEGIA 78 0.0179
215 HYPERNATRAEMIA 89 0.0178
216 DISORIENTATION 707 0.0178
217 MULTIPLE ALLERGIES 139 0.0177
218 BRAIN INJURY 177 0.0176
219 INCOHERENT 114 0.0176
220 PANIC REACTION 127 0.0176
221 EOSINOPHIL COUNT INCREASED 146 0.0175
222 NIGHTMARE 606 0.0175
223 BUNDLE BRANCH BLOCK RIGHT 80 0.0174
224 TACHYCARDIA 1547 0.0174
225 HYPERAMMONAEMIA 87 0.0174
226 RESTLESS LEGS SYNDROME 316 0.0174
227 RHABDOMYOLYSIS 724 0.0173
228 APNOEA 135 0.0173
229 URINARY RETENTION 578 0.0173
230 LEFT VENTRICULAR DYSFUNCTION 115 0.0172
231 DEVELOPMENTAL DELAY 154 0.0171
232 DRUG LEVEL BELOW THERAPEUTIC 94 0.0170
233 ILEUS PARALYTIC 76 0.0170
234 PERSONALITY CHANGE 158 0.0170
235 BLOOD CREATINE PHOSPHOKINASE INCREASED 489 0.0170
236 ABDOMINAL TENDERNESS 84 0.0169
237 HYPERVENTILATION 98 0.0169
238 SOMNAMBULISM 110 0.0167
239 MUSCLE SPASTICITY 205 0.0167
240 PRE-EXISTING CONDITION IMPROVED 104 0.0166
241 IMPULSIVE BEHAVIOUR 62 0.0165
242 UPPER-AIRWAY COUGH SYNDROME 136 0.0165
243 DISTURBANCE IN ATTENTION 888 0.0164
244 PULMONARY MASS 244 0.0164
245 MENTAL IMPAIRMENT 397 0.0164
246 DECREASED INTEREST 96 0.0163
247 SPINAL OSTEOARTHRITIS 143 0.0163
248 BLOOD CALCIUM DECREASED 183 0.0163
249 GASTROINTESTINAL MOTILITY DISORDER 87 0.0162
250 SEIZURE 1876 0.0162
251 PSYCHIATRIC SYMPTOM 119 0.0161
252 PREMATURE LABOUR 91 0.0161
253 FAECALOMA 88 0.0160
254 GRAND MAL CONVULSION 148 0.0160
255 FEELING DRUNK 119 0.0160
256 ARTERIOSCLEROSIS 150 0.0159
257 MUSCLE DISORDER 129 0.0159
258 DYSKINESIA 647 0.0159
259 TRISMUS 82 0.0159
260 SKIN ABRASION 75 0.0159
261 ENCEPHALOPATHY 388 0.0158
262 ABNORMAL BEHAVIOUR 625 0.0158
263 PULMONARY OEDEMA 696 0.0155
264 INTENTIONAL PRODUCT MISUSE 1358 0.0155
265 HEPATIC CYTOLYSIS 197 0.0154
266 HYPERPYREXIA 65 0.0153
267 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 157 0.0153
268 THINKING ABNORMAL 284 0.0152
269 CONGESTIVE CARDIOMYOPATHY 63 0.0151
270 MYOCARDITIS 173 0.0151
271 CIRCULATORY COLLAPSE 257 0.0151
272 BRUXISM 81 0.0150
273 OVERDOSE 3220 0.0149
274 SCOLIOSIS 92 0.0148
275 VENTRICULAR SEPTAL DEFECT 85 0.0148
276 ATELECTASIS 143 0.0148
277 CHOLELITHIASIS 484 0.0147
278 DRUG TOLERANCE 74 0.0146
279 EPILEPSY 447 0.0146
280 DYSPHEMIA 63 0.0144
281 INTESTINAL ISCHAEMIA 79 0.0143
282 HALLUCINATION, VISUAL 302 0.0143
283 EXTRAPYRAMIDAL DISORDER 355 0.0143
284 FOETAL DEATH 74 0.0143
285 ATRIAL SEPTAL DEFECT 119 0.0142
286 HEPATOTOXICITY 316 0.0142
287 APATHY 207 0.0142
288 EYE MOVEMENT DISORDER 97 0.0142
289 ORTHOSTATIC HYPOTENSION 244 0.0140
290 HYPOKINESIA 202 0.0139
291 ANGER 469 0.0139
292 SENSORY DISTURBANCE 222 0.0138
293 INGUINAL HERNIA 84 0.0138
294 ELECTROCARDIOGRAM ABNORMAL 108 0.0138
295 CONFUSIONAL STATE 2222 0.0137
296 MOOD SWINGS 432 0.0135
297 TACHYPNOEA 183 0.0134
298 OBESITY 214 0.0134
299 SLEEP APNOEA SYNDROME 256 0.0134
300 HYPERLIPIDAEMIA 160 0.0134
301 DRUG WITHDRAWAL SYNDROME 1174 0.0134
302 EUPHORIC MOOD 137 0.0134
303 MOTOR DYSFUNCTION 136 0.0133
304 BRADYCARDIA 704 0.0133
305 PAROSMIA 100 0.0132
306 PREMATURE DELIVERY 211 0.0132
307 KLEBSIELLA INFECTION 67 0.0132
308 TRICUSPID VALVE INCOMPETENCE 105 0.0132
309 OLIGURIA 82 0.0132
310 REFUSAL OF TREATMENT BY PATIENT 86 0.0132
311 HEPATOMEGALY 129 0.0131
312 COGNITIVE DISORDER 611 0.0131
313 INTERVERTEBRAL DISC DEGENERATION 121 0.0131
314 PARALYSIS 186 0.0130
315 HYPERAESTHESIA 106 0.0129
316 DYSGRAPHIA 85 0.0129
317 SCREAMING 82 0.0129
318 ECONOMIC PROBLEM 195 0.0129
319 URINARY INCONTINENCE 379 0.0128
320 MENTAL DISORDER 554 0.0127
321 POOR QUALITY SLEEP 274 0.0127
322 LOSS OF CONSCIOUSNESS 1626 0.0127
323 VITAMIN D DEFICIENCY 123 0.0126
324 BLEPHAROSPASM 79 0.0125
325 AMNESIA 816 0.0125
326 IMPAIRED DRIVING ABILITY 141 0.0124
327 DYSLIPIDAEMIA 63 0.0124
328 BLOOD POTASSIUM INCREASED 201 0.0124
329 HALLUCINATION 931 0.0123
330 OBSESSIVE-COMPULSIVE DISORDER 99 0.0123
331 DIABETIC NEUROPATHY 61 0.0123
332 RENAL INJURY 365 0.0123
333 AFFECT LABILITY 118 0.0122
334 APHASIA 369 0.0122
335 CARDIOMYOPATHY 180 0.0122
336 DEPRESSED MOOD 643 0.0122
337 SLEEP DISORDER 858 0.0121
338 BLOOD LACTIC ACID INCREASED 64 0.0121
339 ATRIOVENTRICULAR BLOCK COMPLETE 81 0.0121
340 PREMATURE BABY 364 0.0121
341 AFFECTIVE DISORDER 95 0.0121
342 MAJOR DEPRESSION 88 0.0120
343 CARDIOGENIC SHOCK 172 0.0120
344 SPEECH DISORDER 628 0.0120
345 DRUG WITHDRAWAL SYNDROME NEONATAL 177 0.0119
346 MUSCLE TWITCHING 275 0.0119
347 MENTAL STATUS CHANGES 331 0.0119
348 TREMOR 1977 0.0119
349 ANXIETY 3388 0.0119
350 CARDIOTOXICITY 106 0.0119
351 HYPOXIA 418 0.0119
352 RENAL TUBULAR NECROSIS 116 0.0118
353 IRRITABILITY 704 0.0117
354 HYPERHIDROSIS 1498 0.0116
355 ACCIDENT 138 0.0115
356 LETHARGY 660 0.0115
357 HEAD INJURY 362 0.0114
358 ACUTE KIDNEY INJURY 1749 0.0114
359 HYPOTENSION 2290 0.0114
360 BIPOLAR DISORDER 124 0.0114
361 BALANCE DISORDER 979 0.0113
362 SWOLLEN TONGUE 353 0.0113
363 HEART RATE ABNORMAL 63 0.0113
364 ABNORMAL LOSS OF WEIGHT 77 0.0113
365 MULTIPLE INJURIES 71 0.0113
366 VENTRICULAR TACHYCARDIA 186 0.0113
367 NEUTROPHILIA 64 0.0112
368 HEPATOCELLULAR INJURY 159 0.0112
369 PRODUCT ADMINISTRATION INTERRUPTED 88 0.0112
370 RENAL CYST 89 0.0112
371 EMPHYSEMA 113 0.0112
372 DRUG DEPENDENCE 1799 0.0112
373 OSTEOPENIA 169 0.0111
374 MENSTRUAL DISORDER 92 0.0111
375 EMOTIONAL DISORDER 341 0.0110
376 BLADDER DISORDER 109 0.0110
377 MUSCLE TIGHTNESS 177 0.0109
378 DEPRESSION 2449 0.0108
379 ACUTE RESPIRATORY DISTRESS SYNDROME 190 0.0107
380 NEURALGIA 260 0.0107
381 MOVEMENT DISORDER 343 0.0107
382 METABOLIC ACIDOSIS 340 0.0106
383 BLOOD SODIUM DECREASED 200 0.0106
384 CONVULSION 606 0.0106
385 RESPIRATION ABNORMAL 73 0.0106
386 SUPRAVENTRICULAR TACHYCARDIA 101 0.0105
387 FEAR 283 0.0105
388 LOW BIRTH WEIGHT BABY 83 0.0104
389 BEDRIDDEN 136 0.0103
390 POLYURIA 84 0.0102
391 BLOOD BILIRUBIN INCREASED 277 0.0102
392 ANAL INCONTINENCE 92 0.0102
393 CONCUSSION 79 0.0102
394 RESPIRATORY FAILURE 739 0.0101
395 RENAL FAILURE 1342 0.0101
396 BLOOD MAGNESIUM DECREASED 87 0.0101
397 MUSCLE STRAIN 87 0.0100
398 HYPERPROLACTINAEMIA 65 0.0100
399 VENTRICULAR EXTRASYSTOLES 104 0.0100
400 THERMAL BURN 71 0.0100
401 LEUKOCYTOSIS 181 0.0100
402 TREATMENT NONCOMPLIANCE 545 0.0100
403 ACUTE HEPATIC FAILURE 136 0.0099
404 HYPERSOMNIA 285 0.0099
405 WHITE BLOOD CELL COUNT INCREASED 381 0.0099
406 GAMMA-GLUTAMYLTRANSFERASE INCREASED 220 0.0099
407 MATERNAL DRUGS AFFECTING FOETUS 76 0.0099
408 IMPAIRED GASTRIC EMPTYING 134 0.0098
409 EATING DISORDER 209 0.0098
410 HYPONATRAEMIA 549 0.0097
411 SENSATION OF FOREIGN BODY 82 0.0097
412 ABNORMAL DREAMS 268 0.0097
413 RESPIRATORY DISTRESS 267 0.0097
414 NEUTROPENIC SEPSIS 69 0.0097
415 BLOOD LACTATE DEHYDROGENASE INCREASED 153 0.0096
416 OXYGEN SATURATION DECREASED 542 0.0096
417 MITRAL VALVE INCOMPETENCE 109 0.0096
418 URINE OUTPUT DECREASED 84 0.0096
419 DENTAL CARIES 106 0.0096
420 DECUBITUS ULCER 78 0.0096
421 CAESAREAN SECTION 111 0.0095
422 ROAD TRAFFIC ACCIDENT 396 0.0095
423 CRYING 344 0.0095
424 RESPIRATORY RATE INCREASED 83 0.0093
425 FEELING JITTERY 178 0.0093
426 PALLOR 254 0.0093
427 TINNITUS 427 0.0093
428 HYPOAESTHESIA ORAL 140 0.0093
429 ANHEDONIA 244 0.0093
430 INSOMNIA 2470 0.0093
431 TARDIVE DYSKINESIA 261 0.0092
432 INTERVERTEBRAL DISC PROTRUSION 202 0.0092
433 MYOCARDIAL ISCHAEMIA 105 0.0092
434 FIBROMYALGIA 224 0.0092
435 FULL BLOOD COUNT ABNORMAL 97 0.0092
436 LYMPHOCYTE COUNT DECREASED 161 0.0091
437 FACIAL PAIN 81 0.0091
438 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 473 0.0091
439 SPINAL PAIN 106 0.0090
440 COLITIS ISCHAEMIC 61 0.0090
441 CHOKING 176 0.0090
442 NERVE INJURY 100 0.0090
443 RESPIRATORY TRACT INFECTION 234 0.0090
444 TUBULOINTERSTITIAL NEPHRITIS 168 0.0090
445 HYPOKALAEMIA 413 0.0089
446 HEPATITIS C 108 0.0089
447 CANDIDA INFECTION 151 0.0089
448 ACUTE RESPIRATORY FAILURE 172 0.0089
449 MEMORY IMPAIRMENT 1226 0.0089
450 SPLENOMEGALY 104 0.0089
451 SKIN LACERATION 96 0.0088
452 NEPHROPATHY 82 0.0088
453 IRON DEFICIENCY ANAEMIA 81 0.0088
454 STEVENS-JOHNSON SYNDROME 195 0.0088
455 HIATUS HERNIA 113 0.0087
456 SLUGGISHNESS 89 0.0087
457 NERVE COMPRESSION 80 0.0087
458 CHOLECYSTITIS 103 0.0086
459 FOETAL EXPOSURE DURING PREGNANCY 701 0.0086
460 LACERATION 81 0.0086
461 JOINT DISLOCATION 91 0.0086
462 BLOOD UREA INCREASED 144 0.0086
463 INCREASED APPETITE 164 0.0086
464 FALL 2843 0.0085
465 CHOLESTASIS 164 0.0085
466 INITIAL INSOMNIA 87 0.0085
467 HYPERKALAEMIA 296 0.0084
468 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 217 0.0084
469 ROTATOR CUFF SYNDROME 108 0.0084
470 LIGAMENT SPRAIN 83 0.0084
471 RESPIRATORY DISORDER 251 0.0084
472 MUSCLE ATROPHY 106 0.0084
473 CARPAL TUNNEL SYNDROME 117 0.0083
474 ELECTROLYTE IMBALANCE 97 0.0083
475 LIVER FUNCTION TEST ABNORMAL 242 0.0083
476 NECK PAIN 464 0.0083
477 ORAL DISCOMFORT 115 0.0083
478 EOSINOPHILIA 145 0.0083
479 PRESCRIBED OVERDOSE 160 0.0083
480 NOCTURIA 100 0.0082
481 UROSEPSIS 76 0.0082
482 DIPLOPIA 213 0.0082
483 HICCUPS 67 0.0082
484 HEMIPARESIS 138 0.0081
485 MOOD ALTERED 222 0.0081
486 PHOTOPHOBIA 153 0.0081
487 LOSS OF LIBIDO 73 0.0081
488 COLD SWEAT 143 0.0081
489 MASS 113 0.0081
490 BLOOD ALBUMIN DECREASED 64 0.0081
491 OSTEOARTHRITIS 341 0.0080
492 MOUTH ULCERATION 169 0.0080
493 VENTRICULAR FIBRILLATION 89 0.0080
494 GAIT DISTURBANCE 1530 0.0080
495 HYPOGLYCAEMIA 387 0.0080
496 TEMPERATURE INTOLERANCE 82 0.0079
497 RIB FRACTURE 163 0.0079
498 MULTIPLE ORGAN DYSFUNCTION SYNDROME 224 0.0079
499 ERECTILE DYSFUNCTION 203 0.0079
500 GASTRITIS 208 0.0079
501 PNEUMONIA 2546 0.0079
502 ARRHYTHMIA 372 0.0078
503 SEXUAL DYSFUNCTION 92 0.0078
504 VERTIGO 478 0.0078
505 PELVIC FRACTURE 61 0.0078
506 CONSTIPATION 1705 0.0078
507 IRRITABLE BOWEL SYNDROME 167 0.0078
508 HEART RATE INCREASED 771 0.0078
509 DRY MOUTH 631 0.0078
510 PARAESTHESIA 1223 0.0078
511 FEELING COLD 216 0.0078
512 DYSPHAGIA 736 0.0077
513 NERVOUSNESS 405 0.0077
514 AGRANULOCYTOSIS 144 0.0077
515 SCAR 132 0.0077
516 OESOPHAGITIS 84 0.0077
517 PULMONARY HYPERTENSION 160 0.0077
518 GASTROOESOPHAGEAL REFLUX DISEASE 618 0.0077
519 ACTIVITIES OF DAILY LIVING IMPAIRED 152 0.0077
520 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 73 0.0076
521 PALPITATIONS 893 0.0076
522 MICTURITION URGENCY 87 0.0076
523 BLOOD URINE PRESENT 144 0.0076
524 LIMB INJURY 206 0.0076
525 EAR PAIN 147 0.0076
526 DIZZINESS POSTURAL 73 0.0075
527 GROIN PAIN 66 0.0075
528 ALANINE AMINOTRANSFERASE INCREASED 460 0.0075
529 C-REACTIVE PROTEIN INCREASED 272 0.0075
530 HAEMATEMESIS 189 0.0074
531 QUALITY OF LIFE DECREASED 100 0.0074
532 ANOREXIA 96 0.0074
533 FEEDING DISORDER 151 0.0074
534 ABNORMAL FAECES 61 0.0074
535 SHOCK 171 0.0074
536 MUSCLE SPASMS 1358 0.0074
537 TOOTHACHE 133 0.0073
538 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 402 0.0073
539 HYPERTHYROIDISM 106 0.0073
540 PHARYNGEAL SWELLING 71 0.0072
541 ABASIA 179 0.0072
542 HYPOPHAGIA 185 0.0072
543 DECREASED ACTIVITY 78 0.0072
544 ORAL CANDIDIASIS 95 0.0072
545 SPINAL DISORDER 68 0.0072
546 SYNCOPE 715 0.0071
547 PHOTOSENSITIVITY REACTION 118 0.0071
548 PLATELET COUNT INCREASED 93 0.0071
549 BLOOD TRIGLYCERIDES INCREASED 126 0.0071
550 FOOT FRACTURE 135 0.0071
551 BLOOD ALKALINE PHOSPHATASE INCREASED 176 0.0071
552 LOWER RESPIRATORY TRACT INFECTION 322 0.0071
553 LYMPHADENOPATHY 250 0.0071
554 HEAD DISCOMFORT 125 0.0071
555 NO THERAPEUTIC RESPONSE 86 0.0070
556 MUSCULOSKELETAL CHEST PAIN 109 0.0070
557 DYSURIA 259 0.0070
558 TENDERNESS 73 0.0070
559 MALNUTRITION 78 0.0070
560 HYPOTHYROIDISM 222 0.0069
561 MOBILITY DECREASED 499 0.0069
562 PULMONARY EMBOLISM 660 0.0069
563 THIRST 124 0.0069
564 URINARY TRACT INFECTION 1179 0.0069
565 HEPATIC FUNCTION ABNORMAL 256 0.0069
566 MUSCULOSKELETAL STIFFNESS 600 0.0068
567 TRANSIENT ISCHAEMIC ATTACK 231 0.0068
568 VISION BLURRED 940 0.0068
569 HYPERCHOLESTEROLAEMIA 66 0.0068
570 BACK DISORDER 111 0.0068
571 CONDITION AGGRAVATED 2072 0.0068
572 INJURY 479 0.0068
573 BODY TEMPERATURE INCREASED 139 0.0068
574 POLLAKIURIA 284 0.0068
575 BONE DISORDER 124 0.0068
576 HYPERTENSION 1441 0.0068
577 COAGULOPATHY 113 0.0068
578 OCULAR DISCOMFORT 76 0.0068
579 BURSITIS 82 0.0068
580 OSTEOPOROSIS 278 0.0068
581 LIP SWELLING 225 0.0067
582 MATERNAL EXPOSURE DURING PREGNANCY 602 0.0067
583 HYPOMAGNESAEMIA 94 0.0067
584 CONJUNCTIVITIS 125 0.0067
585 BLOOD CHOLESTEROL INCREASED 314 0.0067
586 NERVOUS SYSTEM DISORDER 210 0.0067
587 MULTI-ORGAN FAILURE 116 0.0067
588 MUSCULAR WEAKNESS 762 0.0067
589 CENTRAL NERVOUS SYSTEM LESION 92 0.0067
590 MULTIPLE SCLEROSIS RELAPSE 458 0.0067
591 SMALL INTESTINAL OBSTRUCTION 82 0.0067
592 HYPERTENSIVE CRISIS 74 0.0066
593 HYPOAESTHESIA 995 0.0066
594 DIABETES MELLITUS INADEQUATE CONTROL 117 0.0066
595 HEPATIC FAILURE 199 0.0066
596 VOMITING 3103 0.0066
597 WRIST FRACTURE 79 0.0066
598 ANKLE FRACTURE 102 0.0066
599 HYPERCALCAEMIA 81 0.0066
600 SWELLING FACE 426 0.0065
601 PHARYNGITIS 81 0.0065
602 DISABILITY 129 0.0065
603 MIGRAINE 622 0.0065
604 MEDICATION ERROR 362 0.0065
605 CHEST PAIN 1204 0.0065
606 PNEUMOTHORAX 103 0.0065
607 SPINAL OPERATION 80 0.0065
608 TYPE 2 DIABETES MELLITUS 218 0.0065
609 EYE INFECTION 73 0.0065
610 BLOOD PRESSURE DECREASED 429 0.0065
611 GINGIVAL BLEEDING 88 0.0064
612 GASTRIC ULCER 122 0.0064
613 RED BLOOD CELL SEDIMENTATION RATE INCREASED 71 0.0064
614 IMPAIRED QUALITY OF LIFE 92 0.0064
615 BLOOD POTASSIUM DECREASED 192 0.0064
616 GASTROENTERITIS 93 0.0064
617 CONTUSION 612 0.0064
618 CYSTITIS 202 0.0063
619 DIABETES MELLITUS 483 0.0063
620 BACK PAIN 1472 0.0063
621 HAEMATOMA 164 0.0063
622 OEDEMA PERIPHERAL 771 0.0063
623 SEPTIC SHOCK 275 0.0063
624 DRUG LEVEL DECREASED 64 0.0063
625 FEELING ABNORMAL 1506 0.0063
626 ILEUS 78 0.0063
627 WEIGHT INCREASED 1402 0.0063
628 MULTIPLE SCLEROSIS 299 0.0062
629 DRUG EXPOSURE DURING PREGNANCY 212 0.0062
630 IMPAIRED WORK ABILITY 133 0.0062
631 VISUAL ACUITY REDUCED 206 0.0062
632 BLISTER 347 0.0062
633 EJECTION FRACTION DECREASED 96 0.0062
634 BODY HEIGHT DECREASED 66 0.0062
635 HAEMOPTYSIS 172 0.0062
636 DYSSTASIA 180 0.0062
637 FRACTURE 116 0.0061
638 DECREASED APPETITE 1423 0.0061
639 NIGHT SWEATS 196 0.0061
640 DIZZINESS 3032 0.0061
641 DEHYDRATION 808 0.0061
642 DRUG RESISTANCE 155 0.0060
643 TRANSAMINASES INCREASED 134 0.0060
644 GLOMERULAR FILTRATION RATE DECREASED 74 0.0060
645 BLOOD CREATININE INCREASED 393 0.0060
646 WHEEZING 356 0.0060
647 SECRETION DISCHARGE 75 0.0060
648 HYPOCALCAEMIA 113 0.0060
649 BRONCHOSPASM 85 0.0060
650 BRAIN FOG 93 0.0059
651 CORONARY ARTERY OCCLUSION 81 0.0059
652 HEPATIC ENZYME INCREASED 402 0.0059
653 TOOTH DISORDER 131 0.0059
654 BACK INJURY 64 0.0059
655 SKIN INFECTION 66 0.0059
656 LIMB DISCOMFORT 182 0.0059
657 EYE PAIN 330 0.0058
658 PYREXIA 2019 0.0058
659 POST PROCEDURAL COMPLICATION 112 0.0058
660 PANCREATITIS ACUTE 131 0.0058
661 PERIPHERAL COLDNESS 80 0.0058
662 MUSCULOSKELETAL PAIN 303 0.0058
663 HEART RATE IRREGULAR 130 0.0057
664 WEIGHT DECREASED 1601 0.0057
665 ABDOMINAL DISTENSION 597 0.0057
666 DEVICE RELATED INFECTION 88 0.0057
667 TOOTH FRACTURE 63 0.0057
668 MALAISE 2504 0.0057
669 HAEMATOCRIT DECREASED 113 0.0057
670 THROAT TIGHTNESS 154 0.0057
671 MIDDLE INSOMNIA 106 0.0057
672 REBOUND EFFECT 64 0.0057
673 SKIN DISCOLOURATION 260 0.0057
674 ANGINA PECTORIS 162 0.0056
675 SCIATICA 90 0.0056
676 EAR INFECTION 150 0.0056
677 DEEP VEIN THROMBOSIS 365 0.0056
678 PARAESTHESIA ORAL 81 0.0056
679 INTESTINAL OBSTRUCTION 211 0.0056
680 RENAL IMPAIRMENT 469 0.0056
681 HEART RATE DECREASED 196 0.0056
682 JAUNDICE 150 0.0056
683 PRESCRIBED UNDERDOSE 111 0.0056
684 ASTHENIA 2091 0.0056
685 LOCAL SWELLING 97 0.0056
686 STAPHYLOCOCCAL INFECTION 183 0.0055
687 HYPERGLYCAEMIA 202 0.0055
688 DYSPHONIA 324 0.0055
689 RASH MACULO-PAPULAR 123 0.0055
690 VISUAL IMPAIRMENT 685 0.0055
691 MYALGIA 938 0.0055
692 APHONIA 77 0.0055
693 SKIN LESION 151 0.0055
694 FOOT DEFORMITY 61 0.0055
695 VASCULITIS 64 0.0055
696 HEPATIC CIRRHOSIS 103 0.0055
697 NEUROTOXICITY 96 0.0055
698 SEPSIS 611 0.0055
699 TOOTH INFECTION 72 0.0055
700 JOINT STIFFNESS 143 0.0054
701 DYSPNOEA 3080 0.0054
702 PAIN IN JAW 154 0.0054
703 HAEMORRHOIDS 106 0.0054
704 NEPHROLITHIASIS 249 0.0054
705 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 260 0.0054
706 FEELING HOT 330 0.0054
707 VIRAL INFECTION 179 0.0054
708 GASTROENTERITIS VIRAL 97 0.0054
709 THERAPY NON-RESPONDER 241 0.0054
710 TENDONITIS 83 0.0054
711 CELLULITIS 268 0.0053
712 NAUSEA 4204 0.0053
713 LOWER LIMB FRACTURE 102 0.0053
714 PAIN IN EXTREMITY 1556 0.0053
715 ASPARTATE AMINOTRANSFERASE INCREASED 280 0.0053
716 PAIN 3236 0.0053
717 BRONCHITIS 389 0.0053
718 THYROID DISORDER 81 0.0052
719 GENERAL PHYSICAL HEALTH DETERIORATION 605 0.0052
720 MUSCULOSKELETAL DISCOMFORT 90 0.0052
721 HEADACHE 3272 0.0052
722 CORONARY ARTERY DISEASE 158 0.0052
723 PHARYNGEAL OEDEMA 80 0.0052
724 INFUSION SITE PAIN 67 0.0052
725 RENAL FAILURE ACUTE 220 0.0052
726 DYSPEPSIA 510 0.0052
727 CHROMATURIA 116 0.0051
728 EMOTIONAL DISTRESS 621 0.0051
729 UPPER LIMB FRACTURE 102 0.0051
730 GENERALISED OEDEMA 63 0.0051
731 CYST 63 0.0051
732 BLOOD PRESSURE FLUCTUATION 121 0.0050
733 PRURITUS GENERALISED 109 0.0050
734 THERAPEUTIC RESPONSE UNEXPECTED 226 0.0050
735 EXPOSURE DURING PREGNANCY 313 0.0050
736 BURNING SENSATION 353 0.0050
737 UPPER RESPIRATORY TRACT INFECTION 232 0.0050
738 GASTRIC DISORDER 172 0.0050
739 PANCREATITIS 263 0.0050
740 ABSCESS 79 0.0049
741 UPPER GASTROINTESTINAL HAEMORRHAGE 83 0.0049
742 INFLUENZA LIKE ILLNESS 406 0.0049
743 WOUND 137 0.0049
744 BONE PAIN 287 0.0049
745 BLOOD PRESSURE INCREASED 749 0.0049
746 WHITE BLOOD CELL COUNT DECREASED 531 0.0049
747 FATIGUE 3808 0.0049
748 PERICARDIAL EFFUSION 113 0.0049
749 DEMENTIA 136 0.0049
750 BLINDNESS 198 0.0049
751 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 83 0.0048
752 DRUG PRESCRIBING ERROR 93 0.0048
753 LUNG DISORDER 236 0.0048
754 BLOOD COUNT ABNORMAL 73 0.0048
755 LIVER INJURY 118 0.0048
756 CHEST DISCOMFORT 491 0.0048
757 NEUTROPHIL COUNT DECREASED 195 0.0048
758 GLAUCOMA 92 0.0048
759 BLOOD TEST ABNORMAL 67 0.0048
760 ABDOMINAL PAIN UPPER 981 0.0048
761 DISSEMINATED INTRAVASCULAR COAGULATION 67 0.0048
762 HOT FLUSH 358 0.0047
763 SPINAL FRACTURE 95 0.0047
764 DRUG ERUPTION 84 0.0047
765 BONE DENSITY DECREASED 148 0.0047
766 RED BLOOD CELL COUNT DECREASED 135 0.0047
767 LOCALISED INFECTION 114 0.0047
768 OSTEOMYELITIS 85 0.0047
769 NEUROPATHY PERIPHERAL 446 0.0047
770 KIDNEY INFECTION 92 0.0047
771 ABDOMINAL PAIN 1087 0.0047
772 RASH MACULAR 163 0.0047
773 INTENTIONAL PRODUCT USE ISSUE 407 0.0046
774 BACTERIAL INFECTION 86 0.0046
775 OEDEMA 250 0.0046
776 WRONG TECHNIQUE IN DRUG USAGE PROCESS 167 0.0046
777 GAIT INABILITY 153 0.0046
778 CHILLS 536 0.0046
779 AMENORRHOEA 80 0.0046
780 RECTAL HAEMORRHAGE 196 0.0046
781 FLUSHING 458 0.0045
782 SINUS DISORDER 89 0.0045
783 LACTIC ACIDOSIS 145 0.0045
784 BLOOD PRESSURE ABNORMAL 89 0.0045
785 UNEVALUABLE EVENT 337 0.0044
786 PLEURAL EFFUSION 271 0.0044
787 LUNG NEOPLASM MALIGNANT 182 0.0044
788 FLATULENCE 251 0.0044
789 FEMUR FRACTURE 137 0.0044
790 LEUKOPENIA 221 0.0044
791 PRODUCT ADMINISTRATION ERROR 89 0.0044
792 PERIPHERAL SWELLING 678 0.0044
793 JOINT INJURY 94 0.0044
794 MULTIPLE FRACTURES 72 0.0044
795 DIVERTICULITIS 121 0.0044
796 CONTRAINDICATED PRODUCT ADMINISTERED 131 0.0043
797 SKIN DISORDER 144 0.0043
798 CARDIAC FAILURE 346 0.0043
799 LIVER DISORDER 191 0.0043
800 HEPATITIS 110 0.0043
801 THERAPY CESSATION 220 0.0043
802 SURGERY 251 0.0043
803 ACUTE MYOCARDIAL INFARCTION 126 0.0043
804 CARDIAC DISORDER 399 0.0043
805 CEREBRAL INFARCTION 104 0.0043
806 DIABETIC KETOACIDOSIS 102 0.0042
807 DIARRHOEA 2727 0.0042
808 INFLUENZA 471 0.0042
809 RETCHING 90 0.0042
810 FACE OEDEMA 71 0.0042
811 HAEMATURIA 144 0.0042
812 PERITONITIS 87 0.0042
813 ATRIAL FIBRILLATION 409 0.0042
814 COUGH 1171 0.0042
815 PRODUCT SUBSTITUTION ISSUE 239 0.0041
816 TOOTH LOSS 86 0.0041
817 HIP FRACTURE 133 0.0041
818 ARTHRALGIA 1718 0.0041
819 ABDOMINAL DISCOMFORT 688 0.0041
820 SINUSITIS 420 0.0041
821 NEUTROPENIA 555 0.0041
822 ARTHRITIS 321 0.0041
823 HAEMOGLOBIN DECREASED 419 0.0041
824 ORAL PAIN 91 0.0041
825 OROPHARYNGEAL PAIN 376 0.0041
826 OFF LABEL USE 3551 0.0041
827 MELAENA 89 0.0040
828 PRODUCTIVE COUGH 192 0.0040
829 PRODUCT USE IN UNAPPROVED INDICATION 995 0.0040
830 SWELLING 373 0.0040
831 EYE DISORDER 131 0.0040
832 EPISTAXIS 298 0.0040
833 FAECES DISCOLOURED 86 0.0040
834 FUNGAL INFECTION 132 0.0040
835 IMPAIRED HEALING 130 0.0040
836 RENAL DISORDER 184 0.0039
837 PRESYNCOPE 96 0.0039
838 CATARACT 235 0.0039
839 DEATH 3389 0.0039
840 HERNIA 76 0.0039
841 MYOCARDIAL INFARCTION 685 0.0039
842 HYPOACUSIS 169 0.0039
843 ANAEMIA 747 0.0039
844 ILL-DEFINED DISORDER 237 0.0039
845 GOUT 70 0.0039
846 RASH GENERALISED 101 0.0039
847 ECZEMA 203 0.0039
848 PERICARDITIS 65 0.0039
849 DRUG INEFFECTIVE 5046 0.0038
850 ANAPHYLACTIC REACTION 211 0.0038
851 RASH ERYTHEMATOUS 182 0.0038
852 ARTHROPATHY 211 0.0038
853 MUSCULOSKELETAL DISORDER 72 0.0038
854 DRUG INTOLERANCE 365 0.0038
855 ALOPECIA 741 0.0038
856 DRY EYE 188 0.0038
857 GALLBLADDER DISORDER 67 0.0037
858 INTERNATIONAL NORMALISED RATIO INCREASED 107 0.0037
859 DRUG EFFECT DECREASED 202 0.0037
860 PELVIC PAIN 68 0.0037
861 DEAFNESS 97 0.0037
862 EYE SWELLING 138 0.0037
863 DRUG-INDUCED LIVER INJURY 116 0.0037
864 BLOOD PRESSURE SYSTOLIC INCREASED 72 0.0037
865 RHINORRHOEA 238 0.0037
866 ILLNESS 379 0.0037
867 HERPES ZOSTER 211 0.0037
868 PRODUCT PHYSICAL ISSUE 74 0.0037
869 INFECTION 530 0.0037
870 GASTROINTESTINAL DISORDER 328 0.0037
871 JOINT SWELLING 441 0.0036
872 ANAPHYLACTIC SHOCK 94 0.0036
873 PROCEDURAL PAIN 101 0.0036
874 THROMBOCYTOPENIA 407 0.0036
875 DYSPNOEA EXERTIONAL 137 0.0036
876 PRODUCT USE ISSUE 683 0.0036
877 DISEASE RECURRENCE 172 0.0036
878 SKIN ULCER 93 0.0036
879 ASTHMA 406 0.0036
880 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 255 0.0036
881 PROTEINURIA 68 0.0036
882 GLOSSODYNIA 80 0.0036
883 ADVERSE DRUG REACTION 319 0.0035
884 THERAPEUTIC RESPONSE DECREASED 215 0.0035
885 INFLAMMATION 183 0.0035
886 PRODUCT PRESCRIBING ISSUE 77 0.0035
887 PNEUMONITIS 96 0.0035
888 DYSGEUSIA 260 0.0035
889 PRODUCT PRESCRIBING ERROR 83 0.0035
890 THROMBOSIS 279 0.0035
891 PHARMACEUTICAL PRODUCT COMPLAINT 90 0.0035
892 PANCYTOPENIA 193 0.0034
893 DISCOMFORT 210 0.0034
894 CARDIOVASCULAR DISORDER 87 0.0034
895 ANGIOEDEMA 151 0.0034
896 CARDIAC FAILURE CONGESTIVE 271 0.0034
897 THROAT IRRITATION 151 0.0034
898 CLOSTRIDIUM DIFFICILE INFECTION 73 0.0033
899 HAEMATOCHEZIA 184 0.0033
900 ORAL HERPES 65 0.0033
901 HYPERSENSITIVITY 618 0.0033
902 DRUG ADMINISTRATION ERROR 102 0.0033
903 ASCITES 97 0.0033
904 RASH 1438 0.0033
905 PREGNANCY 66 0.0033
906 LACRIMATION INCREASED 99 0.0033
907 CEREBRAL HAEMORRHAGE 117 0.0033
908 STOMATITIS 198 0.0033
909 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 232 0.0033
910 LABORATORY TEST ABNORMAL 96 0.0032
911 DEVICE USE ERROR 113 0.0032
912 NASAL CONGESTION 191 0.0032
913 HAEMORRHAGE 339 0.0032
914 PSORIATIC ARTHROPATHY 131 0.0032
915 GASTROINTESTINAL HAEMORRHAGE 269 0.0032
916 PLATELET COUNT DECREASED 341 0.0032
917 PRURITUS 1229 0.0032
918 COLITIS 120 0.0032
919 RASH PRURITIC 171 0.0032
920 DERMATITIS 66 0.0031
921 KNEE ARTHROPLASTY 66 0.0031
922 RASH PAPULAR 70 0.0031
923 PRODUCT AVAILABILITY ISSUE 71 0.0031
924 OSTEONECROSIS 102 0.0031
925 ERYTHEMA 637 0.0031
926 CEREBROVASCULAR ACCIDENT 524 0.0031
927 NASOPHARYNGITIS 569 0.0031
928 INTENTIONAL DOSE OMISSION 87 0.0030
929 DEPENDENCE 167 0.0030
930 DEVICE MALFUNCTION 210 0.0030
931 LIVER FUNCTION TEST INCREASED 64 0.0030
932 HOSPITALISATION 457 0.0030
933 INCORRECT ROUTE OF DRUG ADMINISTRATION 106 0.0030
934 FLUID RETENTION 149 0.0029
935 PRODUCT DOSE OMISSION 190 0.0029
936 SKIN EXFOLIATION 242 0.0029
937 DRUG DOSE OMISSION 466 0.0028
938 GLYCOSYLATED HAEMOGLOBIN INCREASED 71 0.0028
939 DRUG EFFECT INCOMPLETE 101 0.0028
940 UNDERDOSE 202 0.0028
941 SYSTEMIC LUPUS ERYTHEMATOSUS 97 0.0027
942 PRODUCT DOSE OMISSION IN ERROR 77 0.0027
943 OSTEONECROSIS OF JAW 65 0.0026
944 OCULAR HYPERAEMIA 123 0.0026
945 BLOOD GLUCOSE INCREASED 487 0.0026
946 URTICARIA 431 0.0026
947 ABDOMINAL PAIN LOWER 64 0.0025
948 COVID-19 440 0.0025
949 PRODUCT QUALITY ISSUE 337 0.0025
950 TREATMENT FAILURE 204 0.0025
951 VAGINAL HAEMORRHAGE 105 0.0024
952 INCORRECT DRUG ADMINISTRATION DURATION 67 0.0024
953 PSORIASIS 308 0.0024
954 INFUSION RELATED REACTION 154 0.0023
955 DISEASE PROGRESSION 273 0.0023
956 THERAPEUTIC RESPONSE SHORTENED 76 0.0023
957 EYE IRRITATION 128 0.0022
958 PRODUCT ADHESION ISSUE 79 0.0022
959 BLOOD GLUCOSE DECREASED 106 0.0022
960 PRODUCT DOSE OMISSION ISSUE 645 0.0022
961 THERAPY INTERRUPTED 155 0.0022
962 FEBRILE NEUTROPENIA 142 0.0021
963 INTERSTITIAL LUNG DISEASE 103 0.0021
964 NEOPLASM MALIGNANT 140 0.0021
965 ADVERSE EVENT 191 0.0021
966 INCORRECT DOSE ADMINISTERED 466 0.0020
967 ABORTION SPONTANEOUS 78 0.0019
968 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 392 0.0019
969 INJECTION SITE MASS 71 0.0019
970 RHEUMATOID ARTHRITIS 216 0.0019
971 DRY SKIN 247 0.0018
972 EYE PRURITUS 62 0.0018
973 EXPIRED PRODUCT ADMINISTERED 61 0.0018
974 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 328 0.0018
975 NO ADVERSE EVENT 325 0.0018
976 INJECTION SITE BRUISING 132 0.0017
977 THERAPEUTIC PRODUCT EFFECT DECREASED 74 0.0017
978 SKIN BURNING SENSATION 118 0.0016
979 DEVICE DISLOCATION 70 0.0016
980 MALIGNANT NEOPLASM PROGRESSION 164 0.0016
981 PLASMA CELL MYELOMA 61 0.0016
982 INJECTION SITE REACTION 107 0.0016
983 SKIN IRRITATION 70 0.0015
984 DEVICE ISSUE 128 0.0014
985 INJECTION SITE PRURITUS 95 0.0014
986 INJECTION SITE ERYTHEMA 174 0.0014
987 BREAST CANCER 129 0.0014
988 ACNE 102 0.0013
989 DERMATITIS ATOPIC 66 0.0013
990 INJECTION SITE PAIN 375 0.0012
991 INJECTION SITE HAEMORRHAGE 90 0.0011
992 INJECTION SITE SWELLING 84 0.0011
993 ACCIDENTAL EXPOSURE TO PRODUCT 111 0.0011